2015
New onset executive function difficulties at menopause: a possible role for lisdexamfetamine
Epperson CN, Shanmugan S, Kim DR, Mathews S, Czarkowski KA, Bradley J, Appleby DH, Iannelli C, Sammel MD, Brown TE. New onset executive function difficulties at menopause: a possible role for lisdexamfetamine. Psychopharmacology 2015, 232: 3091-3100. PMID: 26063677, PMCID: PMC4631394, DOI: 10.1007/s00213-015-3953-7.Peer-Reviewed Original ResearchConceptsBrown Attention-Deficit Disorder ScaleExecutive function difficultiesExecutive functionAttention Deficit Disorder ScaleLDX treatmentObjective cognitive functionMemory taskVerbal memoryVerbal recallCognitive measuresParagraph recallLifetime ADHDCognitive functionCognitive declineDisorder ScaleSubjective measuresMenopausal womenSubscale scoresLisdexamfetamineObjective measuresRecallEarly postmenopausal womenSystolic blood pressureCross-over studyHealthy menopausal women
2014
The relationship of self-reported subclinical obsessive-compulsive symptoms and impulsivity among adults with AD/HD
Brown FC, Katz LJ, Roth RM, Beers SR. The relationship of self-reported subclinical obsessive-compulsive symptoms and impulsivity among adults with AD/HD. Psychiatry Research 2014, 216: 131-136. PMID: 24556290, DOI: 10.1016/j.psychres.2014.01.034.Peer-Reviewed Original ResearchConceptsSubclinical obsessive-compulsive symptomsAD/HDResponse inhibition difficultiesObsessive-compulsive symptomsInhibition difficultiesAttention-deficit/hyperactivity disorderBrown Attention-Deficit Disorder ScaleDeficit/hyperactivity disorderAttention Deficit Disorder ScaleMore commission errorsContinuous Performance TestPerformance-based testsObsessive Compulsive ScaleHyperactivity disorderCommission errorsDisorder ScaleSCL-90Obsessive symptomsCPT IIHigher scoresSecond editionPerformance testsIndividualsAdultsImpulsivity
2011
Impact of atomoxetine on subjective attention and memory difficulties in perimenopausal and postmenopausal women
Epperson CN, Pittman B, Czarkowski KA, Bradley J, Quinlan DM, Brown TE. Impact of atomoxetine on subjective attention and memory difficulties in perimenopausal and postmenopausal women. Menopause The Journal Of The North American Menopause Society 2011, 18: 542-548. PMID: 21293309, PMCID: PMC4076798, DOI: 10.1097/gme.0b013e3181fcafd6.Peer-Reviewed Original ResearchConceptsAttention-deficit/hyperactivity disorderBrown Attention-Deficit Disorder ScaleCognitive difficultiesHistory of ADHDBehavioral assessmentSubjective cognitive difficultiesAttention Deficit Disorder ScaleAttention/concentrationConcentration/attentionShort-term memorySimilar cognitive impairmentsCluster scoresATX treatmentExecutive functionSubjective attentionMemory difficultiesHyperactivity disorderNeuropsychological testsNeuropsychological testingCognitive symptomsDisorder ScaleSubjective difficultyAtomoxetineCognitive impairmentMemory
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply